Delia Deschaine is a partner in the firm’s Global Corporate Practice, where she advises clients on the US Food and Drug Administration (FDA)’s laws, the US Drug Enforcement Administration (DEA)’s laws, and US state-controlled substance and pharmacy laws. Her practice focuses on providing comprehensive counsel to pharmaceutical and biotechnology manufacturers on a diverse array of issues, such as:
